US5469854A
(en)
|
1989-12-22 |
1995-11-28 |
Imarx Pharmaceutical Corp. |
Methods of preparing gas-filled liposomes
|
US5585112A
(en)
|
1989-12-22 |
1996-12-17 |
Imarx Pharmaceutical Corp. |
Method of preparing gas and gaseous precursor-filled microspheres
|
US5580575A
(en)
|
1989-12-22 |
1996-12-03 |
Imarx Pharmaceutical Corp. |
Therapeutic drug delivery systems
|
US6001335A
(en)
|
1989-12-22 |
1999-12-14 |
Imarx Pharmaceutical Corp. |
Contrasting agents for ultrasonic imaging and methods for preparing the same
|
US6146657A
(en)
|
1989-12-22 |
2000-11-14 |
Imarx Pharmaceutical Corp. |
Gas-filled lipid spheres for use in diagnostic and therapeutic applications
|
US5773024A
(en)
*
|
1989-12-22 |
1998-06-30 |
Imarx Pharmaceutical Corp. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
US5776429A
(en)
*
|
1989-12-22 |
1998-07-07 |
Imarx Pharmaceutical Corp. |
Method of preparing gas-filled microspheres using a lyophilized lipids
|
US6551576B1
(en)
|
1989-12-22 |
2003-04-22 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
US5922304A
(en)
|
1989-12-22 |
1999-07-13 |
Imarx Pharmaceutical Corp. |
Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
|
US5305757A
(en)
|
1989-12-22 |
1994-04-26 |
Unger Evan C |
Gas filled liposomes and their use as ultrasonic contrast agents
|
US5656211A
(en)
*
|
1989-12-22 |
1997-08-12 |
Imarx Pharmaceutical Corp. |
Apparatus and method for making gas-filled vesicles of optimal size
|
US5733572A
(en)
*
|
1989-12-22 |
1998-03-31 |
Imarx Pharmaceutical Corp. |
Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
|
US6088613A
(en)
|
1989-12-22 |
2000-07-11 |
Imarx Pharmaceutical Corp. |
Method of magnetic resonance focused surgical and therapeutic ultrasound
|
US5542935A
(en)
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
US20010024638A1
(en)
*
|
1992-11-02 |
2001-09-27 |
Michel Schneider |
Stable microbubble suspensions as enhancement agents for ultrasound echography and dry formulations thereof
|
US6989141B2
(en)
*
|
1990-05-18 |
2006-01-24 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
CA2063529A1
(en)
*
|
1991-03-22 |
1992-09-23 |
Katsuro Tachibana |
Booster for therapy of diseases with ultrasound and pharmaceutical liquid composition containing the same
|
GB9106673D0
(en)
*
|
1991-03-28 |
1991-05-15 |
Hafslund Nycomed As |
Improvements in or relating to contrast agents
|
US5205290A
(en)
|
1991-04-05 |
1993-04-27 |
Unger Evan C |
Low density microspheres and their use as contrast agents for computed tomography
|
US5874062A
(en)
|
1991-04-05 |
1999-02-23 |
Imarx Pharmaceutical Corp. |
Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
|
MX9205298A
(es)
*
|
1991-09-17 |
1993-05-01 |
Steven Carl Quay |
Medios gaseosos de contraste de ultrasonido y metodo para seleccionar gases para usarse como medios de contraste de ultrasonido
|
CA2154590C
(en)
*
|
1993-01-25 |
2001-06-12 |
Steven C. Quay |
Phase shift colloids as ultrasound contrast agents
|
IL108416A
(en)
|
1993-01-25 |
1998-10-30 |
Sonus Pharma Inc |
Colloids with phase difference as contrast ultrasound agents
|
SE504074C2
(sv)
*
|
1993-07-05 |
1996-11-04 |
Pharmacia Ab |
Proteinberedning för subkutan, intramuskulär eller intradermal administrering
|
DE69434119T3
(de)
*
|
1993-07-30 |
2011-05-05 |
Imcor Pharmaceutical Co., San Diego |
Stabilisierte mikrogasbläschen-zusammensetzungen für echographie
|
US5798091A
(en)
|
1993-07-30 |
1998-08-25 |
Alliance Pharmaceutical Corp. |
Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement
|
US6217849B1
(en)
*
|
1993-09-29 |
2001-04-17 |
Bracco Research S.A. |
Liposome suspensions as blood pool imaging contrast agents
|
US7083572B2
(en)
*
|
1993-11-30 |
2006-08-01 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Therapeutic delivery systems
|
PT682530E
(pt)
*
|
1993-12-15 |
2003-06-30 |
Bracco Research Sa |
Misturas de gases uteis como meios de contraste para ultrassons
|
US5736121A
(en)
|
1994-05-23 |
1998-04-07 |
Imarx Pharmaceutical Corp. |
Stabilized homogenous suspensions as computed tomography contrast agents
|
US5792612A
(en)
*
|
1994-06-22 |
1998-08-11 |
Helsinki University Licensing, Ltd. |
Use of lipids to improve the polymerse chain reaction
|
US5730955A
(en)
*
|
1994-08-02 |
1998-03-24 |
Molecular Biosystems, Inc. |
Process for making gas-filled microspheres containing a liquid hydrophobic barrier
|
US5540909A
(en)
*
|
1994-09-28 |
1996-07-30 |
Alliance Pharmaceutical Corp. |
Harmonic ultrasound imaging with microbubbles
|
US6743779B1
(en)
*
|
1994-11-29 |
2004-06-01 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
US6383814B1
(en)
*
|
1994-12-09 |
2002-05-07 |
Genzyme Corporation |
Cationic amphiphiles for intracellular delivery of therapeutic molecules
|
USRE38971E1
(en)
|
1995-01-31 |
2006-02-07 |
Kabushiki Kaisha Toshiba |
Ultrasound diagnostic apparatus and method
|
US5830430A
(en)
|
1995-02-21 |
1998-11-03 |
Imarx Pharmaceutical Corp. |
Cationic lipids and the use thereof
|
US5997898A
(en)
*
|
1995-06-06 |
1999-12-07 |
Imarx Pharmaceutical Corp. |
Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
|
US5902604A
(en)
*
|
1995-06-06 |
1999-05-11 |
Board Of Regents, The University Of Texas System |
Submicron liposome suspensions obtained from preliposome lyophilizates
|
US6521211B1
(en)
|
1995-06-07 |
2003-02-18 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Methods of imaging and treatment with targeted compositions
|
US6033645A
(en)
*
|
1996-06-19 |
2000-03-07 |
Unger; Evan C. |
Methods for diagnostic imaging by regulating the administration rate of a contrast agent
|
US6139819A
(en)
|
1995-06-07 |
2000-10-31 |
Imarx Pharmaceutical Corp. |
Targeted contrast agents for diagnostic and therapeutic use
|
GB9511488D0
(en)
*
|
1995-06-07 |
1995-08-02 |
Nycomed Imaging As |
Improvements in or relating to contrast agents
|
US5897851A
(en)
*
|
1995-06-07 |
1999-04-27 |
Sonus Pharmaceuticals, Inc. |
Nucleation and activation of a liquid-in-liquid emulsion for use in ultrasound imaging
|
US5804162A
(en)
*
|
1995-06-07 |
1998-09-08 |
Alliance Pharmaceutical Corp. |
Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients
|
US6231834B1
(en)
|
1995-06-07 |
2001-05-15 |
Imarx Pharmaceutical Corp. |
Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
|
US5780010A
(en)
*
|
1995-06-08 |
1998-07-14 |
Barnes-Jewish Hospital |
Method of MRI using avidin-biotin conjugated emulsions as a site specific binding system
|
US6821506B2
(en)
|
1995-06-08 |
2004-11-23 |
Barnes-Jewish Hospital |
Site specific binding system, imaging compositions and methods
|
DE19543077C2
(de)
*
|
1995-11-13 |
1997-10-16 |
Schering Ag |
Verwendung von gashaltigen Metallkomplexen als Ultraschallkontrastmittel
|
US5840276A
(en)
*
|
1996-01-11 |
1998-11-24 |
Apfel Enterprises, Inc. |
Activatable infusable dispersions containing drops of a superheated liquid for methods of therapy and diagnosis
|
EP0881915B1
(de)
*
|
1996-02-19 |
2003-04-23 |
Amersham Health AS |
Verbesserungen an (oder im bezug auf) kontrastmittel
|
JP3956402B2
(ja)
*
|
1996-03-04 |
2007-08-08 |
日本油脂株式会社 |
アンホテリシンb運搬体
|
HU226714B1
(en)
*
|
1996-03-05 |
2009-07-28 |
Acusphere |
Microencapsulated fluorinated gases for use as imaging agents
|
US5611344A
(en)
*
|
1996-03-05 |
1997-03-18 |
Acusphere, Inc. |
Microencapsulated fluorinated gases for use as imaging agents
|
JP2947158B2
(ja)
*
|
1996-03-07 |
1999-09-13 |
昭和電工株式会社 |
ヘキサフルオロエタンの製造方法
|
CA2250219C
(en)
|
1996-03-28 |
2008-10-07 |
Hayat Onyuksel |
Materials and methods for making improved liposome compositions
|
EP0935415B1
(de)
*
|
1996-05-01 |
2006-11-22 |
Imarx Pharmaceutical Corp. |
In vitro verfahren zum einbringen von nukleinsäuren in eine zelle
|
US5837221A
(en)
*
|
1996-07-29 |
1998-11-17 |
Acusphere, Inc. |
Polymer-lipid microencapsulated gases for use as imaging agents
|
WO1998007410A1
(en)
*
|
1996-08-19 |
1998-02-26 |
Vivorx Pharmaceuticals, Inc. |
Methods for the production of protein particles useful for delivery of pharmacological agents
|
WO1998007409A1
(en)
*
|
1996-08-23 |
1998-02-26 |
Sequus Pharmaceuticals, Inc. |
Liposomes containing a cisplatin compound
|
US6414139B1
(en)
|
1996-09-03 |
2002-07-02 |
Imarx Therapeutics, Inc. |
Silicon amphiphilic compounds and the use thereof
|
US5846517A
(en)
|
1996-09-11 |
1998-12-08 |
Imarx Pharmaceutical Corp. |
Methods for diagnostic imaging using a renal contrast agent and a vasodilator
|
ATE366588T1
(de)
|
1996-09-11 |
2007-08-15 |
Imarx Pharmaceutical Corp |
Verfahren zur diagnostischen bilderzeugung der nierenregion unter verwendung eines kontrastmittels und eines vasodilators
|
CA2266622C
(en)
*
|
1996-09-27 |
2006-08-15 |
Hyal Pharmaceutical Corporation |
Hyaluronic drug delivery system
|
TR199901544T2
(xx)
|
1996-10-21 |
1999-09-21 |
Nycomed Imaging As |
Kontrast ajanlar�ndaki veya kontrast ajanlar�yla ilgili geli�meler.
|
DE19648664A1
(de)
*
|
1996-11-14 |
1998-05-28 |
Schering Ag |
Wirkstoffhaltige Mikropartikel, diese enthaltende Mittel, deren Verwendung zur ultraschallgesteuerten Freisetzung von Wirkstoffen sowie Verfahren zu deren Herstellung
|
US20020182258A1
(en)
*
|
1997-01-22 |
2002-12-05 |
Zycos Inc., A Delaware Corporation |
Microparticles for delivery of nucleic acid
|
GB9701237D0
(en)
*
|
1997-01-22 |
1997-03-12 |
Nycomed Imaging As |
Improvements in or relating to contrast agents
|
DE19709704C2
(de)
|
1997-03-10 |
1999-11-04 |
Michael Georgieff |
Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
|
US6143276A
(en)
*
|
1997-03-21 |
2000-11-07 |
Imarx Pharmaceutical Corp. |
Methods for delivering bioactive agents to regions of elevated temperatures
|
US6090800A
(en)
|
1997-05-06 |
2000-07-18 |
Imarx Pharmaceutical Corp. |
Lipid soluble steroid prodrugs
|
US6120751A
(en)
|
1997-03-21 |
2000-09-19 |
Imarx Pharmaceutical Corp. |
Charged lipids and uses for the same
|
US6676626B1
(en)
|
1998-05-01 |
2004-01-13 |
Ekos Corporation |
Ultrasound assembly with increased efficacy
|
US6582392B1
(en)
|
1998-05-01 |
2003-06-24 |
Ekos Corporation |
Ultrasound assembly for use with a catheter
|
US6416740B1
(en)
*
|
1997-05-13 |
2002-07-09 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Acoustically active drug delivery systems
|
US6217886B1
(en)
|
1997-07-14 |
2001-04-17 |
The Board Of Trustees Of The University Of Illinois |
Materials and methods for making improved micelle compositions
|
ATE252916T1
(de)
*
|
1997-08-12 |
2003-11-15 |
Bracco Research Sa |
Verabreichbare formulierugen und ihre anwendung in mri
|
US6548047B1
(en)
*
|
1997-09-15 |
2003-04-15 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Thermal preactivation of gaseous precursor filled compositions
|
DK1019022T4
(da)
*
|
1997-09-29 |
2010-11-08 |
Novartis Ag |
Perforerede mikropartikler og fremgangsmåde til anvendelse deraf
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
US8668737B2
(en)
|
1997-10-10 |
2014-03-11 |
Senorx, Inc. |
Tissue marking implant
|
US7637948B2
(en)
|
1997-10-10 |
2009-12-29 |
Senorx, Inc. |
Tissue marking implant
|
AU9550498A
(en)
*
|
1997-10-21 |
1999-05-10 |
Nycomed Imaging As |
Ultrasound imaging with contrast agent targeted to microvasculature and a vasodilator drug
|
US6123923A
(en)
*
|
1997-12-18 |
2000-09-26 |
Imarx Pharmaceutical Corp. |
Optoacoustic contrast agents and methods for their use
|
JPH11244386A
(ja)
*
|
1998-01-01 |
1999-09-14 |
Ge Yokogawa Medical Systems Ltd |
血行阻止方法及び加温装置
|
US20010003580A1
(en)
*
|
1998-01-14 |
2001-06-14 |
Poh K. Hui |
Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
|
US6896659B2
(en)
*
|
1998-02-06 |
2005-05-24 |
Point Biomedical Corporation |
Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility
|
US6161034A
(en)
*
|
1999-02-02 |
2000-12-12 |
Senorx, Inc. |
Methods and chemical preparations for time-limited marking of biopsy sites
|
ATE276745T1
(de)
*
|
1998-04-09 |
2004-10-15 |
Amersham Health As |
Verwendung von teilchenförmigen kontrastmitteln in der diagnostischen bilderzeugung zur untersuchung physiologischer parameter
|
US20030078227A1
(en)
*
|
1998-07-02 |
2003-04-24 |
Greenleaf James F. |
Site-directed transfection with ultrasound and cavitation nuclei
|
US7686763B2
(en)
*
|
1998-09-18 |
2010-03-30 |
University Of Washington |
Use of contrast agents to increase the effectiveness of high intensity focused ultrasound therapy
|
EP1140211A1
(de)
*
|
1998-10-12 |
2001-10-10 |
Mallinckrodt Inc. |
Ultraschall kontrastmitteln
|
US6725083B1
(en)
|
1999-02-02 |
2004-04-20 |
Senorx, Inc. |
Tissue site markers for in VIVO imaging
|
US6862470B2
(en)
|
1999-02-02 |
2005-03-01 |
Senorx, Inc. |
Cavity-filling biopsy site markers
|
US7651505B2
(en)
*
|
2002-06-17 |
2010-01-26 |
Senorx, Inc. |
Plugged tip delivery for marker placement
|
US20090030309A1
(en)
|
2007-07-26 |
2009-01-29 |
Senorx, Inc. |
Deployment of polysaccharide markers
|
US7983734B2
(en)
|
2003-05-23 |
2011-07-19 |
Senorx, Inc. |
Fibrous marker and intracorporeal delivery thereof
|
US9820824B2
(en)
|
1999-02-02 |
2017-11-21 |
Senorx, Inc. |
Deployment of polysaccharide markers for treating a site within a patent
|
US8498693B2
(en)
|
1999-02-02 |
2013-07-30 |
Senorx, Inc. |
Intracorporeal marker and marker delivery device
|
US8361082B2
(en)
|
1999-02-02 |
2013-01-29 |
Senorx, Inc. |
Marker delivery device with releasable plug
|
CN100512879C
(zh)
|
1999-04-23 |
2009-07-15 |
阿尔萨公司 |
用于脂质体中的有可裂解键的缀合物
|
US7238368B2
(en)
|
1999-04-23 |
2007-07-03 |
Alza Corporation |
Releasable linkage and compositions containing same
|
US6575991B1
(en)
|
1999-06-17 |
2003-06-10 |
Inrad, Inc. |
Apparatus for the percutaneous marking of a lesion
|
US6572840B1
(en)
|
1999-07-28 |
2003-06-03 |
Bristol-Myers Squibb Pharma Company |
Stable microbubbles comprised of a perfluoropropane encapsulated lipid moiety for use as an ultrasound contrast agent
|
WO2001012069A1
(en)
*
|
1999-08-13 |
2001-02-22 |
Point Biomedical Corporation |
Hollow microspheres with controlled fragility for medical use
|
US7510536B2
(en)
|
1999-09-17 |
2009-03-31 |
University Of Washington |
Ultrasound guided high intensity focused ultrasound treatment of nerves
|
US7520856B2
(en)
*
|
1999-09-17 |
2009-04-21 |
University Of Washington |
Image guided high intensity focused ultrasound device for therapy in obstetrics and gynecology
|
JP4776843B2
(ja)
|
1999-10-01 |
2011-09-21 |
イムノゲン インコーポレーティッド |
免疫複合体及び化学療法剤を用いる癌治療用組成物及び方法
|
AU2619301A
(en)
|
1999-10-25 |
2001-06-06 |
Therus Corporation |
Use of focused ultrasound for vascular sealing
|
US6626855B1
(en)
|
1999-11-26 |
2003-09-30 |
Therus Corpoation |
Controlled high efficiency lesion formation using high intensity ultrasound
|
US7897140B2
(en)
*
|
1999-12-23 |
2011-03-01 |
Health Research, Inc. |
Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
|
US6960560B2
(en)
*
|
1999-12-30 |
2005-11-01 |
Gwathmey, Inc. |
Iron chelator delivery system
|
DE60139112D1
(de)
*
|
2000-03-06 |
2009-08-13 |
Boston Scient Ltd |
Unter ultralschall sichtbare embolisierende substanzen
|
EP1267834A4
(de)
*
|
2000-03-29 |
2003-08-27 |
Aradigm Corp |
Kationische liposomen
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
WO2001085136A2
(en)
|
2000-05-10 |
2001-11-15 |
Alliance Pharmaceutical Corporation |
Phospholipid-based powders for drug delivery
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
EP2286843A3
(de)
|
2000-06-02 |
2011-08-03 |
Bracco Suisse SA |
Arzneimitteln zur Zielgerichtung von Endothelzellen
|
JP2003535122A
(ja)
*
|
2000-06-02 |
2003-11-25 |
ザイコス インク. |
生物活性物質のための送達システム
|
US6589557B2
(en)
*
|
2000-06-15 |
2003-07-08 |
Acusphere, Inc. |
Porous celecoxib matrices and methods of manufacture thereof
|
US6800297B2
(en)
|
2000-06-15 |
2004-10-05 |
Acusphere, Inc. |
Porous COX-2 inhibitor matrices and methods of manufacture thereof
|
DE60135743D1
(de)
*
|
2000-06-16 |
2008-10-23 |
Sloan Kettering Inst Cancer |
Liposomale einkapselung von alphastrahlern, und deren verwendung
|
US6599441B1
(en)
*
|
2000-07-18 |
2003-07-29 |
Emerald Biostructures, Inc. |
Crystallization solutions
|
US7311893B2
(en)
*
|
2000-07-25 |
2007-12-25 |
Neurochem (International) Limited |
Amyloid targeting imaging agents and uses thereof
|
ES2409758T3
(es)
|
2000-11-20 |
2013-06-27 |
Senorx, Inc. |
Marcadores de sitios tisulares para formación de imagen in vivo
|
DK1347743T3
(da)
*
|
2000-12-07 |
2006-07-03 |
Univ Utrecht Holding Bv |
Præparat til behandling af inflammatoriske lidelser
|
US7179449B2
(en)
*
|
2001-01-30 |
2007-02-20 |
Barnes-Jewish Hospital |
Enhanced ultrasound detection with temperature-dependent contrast agents
|
US20030211045A1
(en)
*
|
2001-02-05 |
2003-11-13 |
Danuta Leszcyznska |
Magnetoliposome composition for targeted treatment of biological tissue and associated methods
|
AU2002307056B2
(en)
*
|
2001-03-30 |
2005-08-04 |
Drexel University |
Echogenic polymer microcapsules and nanocapsules and methods for production and use thereof
|
US7897141B2
(en)
*
|
2002-04-01 |
2011-03-01 |
Drexel University |
Echogenic polymer microcapsules and nanocapsules and methods for production and use thereof
|
DE60226251T2
(de)
*
|
2001-07-10 |
2009-05-14 |
Sonogene, LLC, Glen Ellyn |
Verbesserung der transfektion von dna in die leber
|
US20030215391A1
(en)
*
|
2001-07-19 |
2003-11-20 |
Carlos Rabito |
Fluorescent agents for real-time measurement of organ function
|
US20030044354A1
(en)
*
|
2001-08-16 |
2003-03-06 |
Carpenter Alan P. |
Gas microsphere liposome composites for ultrasound imaging and ultrasound stimulated drug release
|
US7344702B2
(en)
*
|
2004-02-13 |
2008-03-18 |
Bristol-Myers Squibb Pharma Company |
Contrast agents for myocardial perfusion imaging
|
US20050065118A1
(en)
*
|
2001-10-16 |
2005-03-24 |
Jing Wang |
Organosulfur inhibitors of tyrosine phosphatases
|
ATE520362T1
(de)
|
2001-12-03 |
2011-09-15 |
Ekos Corp |
Katheter mit mehreren ultraschall-abstrahlenden teilen
|
TWI324518B
(en)
|
2001-12-19 |
2010-05-11 |
Nektar Therapeutics |
Pulmonary delivery of aminoglycosides
|
US6993394B2
(en)
|
2002-01-18 |
2006-01-31 |
Calfacion Corporation |
System method and apparatus for localized heating of tissue
|
US7048756B2
(en)
|
2002-01-18 |
2006-05-23 |
Apasara Medical Corporation |
System, method and apparatus for evaluating tissue temperature
|
US6850804B2
(en)
|
2002-01-18 |
2005-02-01 |
Calfacior Corporation |
System method and apparatus for localized heating of tissue
|
US7700074B2
(en)
*
|
2002-02-07 |
2010-04-20 |
Pettegrew Jay W |
Method and system for diagnosis of neuropsychiatric disorders including chronic alcoholism
|
US7407778B2
(en)
*
|
2002-02-07 |
2008-08-05 |
Pettegrew Jay W |
Compounds, compositions and methods for treating neuropsychiatric disorders
|
US20050250700A1
(en)
*
|
2002-03-01 |
2005-11-10 |
Sato Aaron K |
KDR and VEGF/KDR binding peptides
|
US7261876B2
(en)
*
|
2002-03-01 |
2007-08-28 |
Bracco International Bv |
Multivalent constructs for therapeutic and diagnostic applications
|
US7794693B2
(en)
|
2002-03-01 |
2010-09-14 |
Bracco International B.V. |
Targeting vector-phospholipid conjugates
|
US7211240B2
(en)
*
|
2002-03-01 |
2007-05-01 |
Bracco International B.V. |
Multivalent constructs for therapeutic and diagnostic applications
|
US7666979B2
(en)
*
|
2002-03-01 |
2010-02-23 |
Bracco International B.V. |
Methods for preparing multivalent constructs for therapeutic and diagnostic applications and methods of preparing the same
|
AU2003278807A1
(en)
|
2002-03-01 |
2004-08-13 |
Bracco International B.V. |
Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
|
US7985402B2
(en)
*
|
2002-03-01 |
2011-07-26 |
Bracco Suisse Sa |
Targeting vector-phospholipid conjugates
|
EP2301587B1
(de)
|
2002-03-01 |
2014-06-25 |
Dyax Corp. |
KDR- und VEGF/KDR-bindende Peptide sowie ihre Verwendung bei der Diagnose und Therapie
|
US8623822B2
(en)
|
2002-03-01 |
2014-01-07 |
Bracco Suisse Sa |
KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
|
US20040076586A1
(en)
*
|
2002-03-28 |
2004-04-22 |
Reinhard Koening |
Compositions and methods for delivering pharmaceutically active agents using nanoparticulates
|
US7462366B2
(en)
|
2002-03-29 |
2008-12-09 |
Boston Scientific Scimed, Inc. |
Drug delivery particle
|
US7094369B2
(en)
*
|
2002-03-29 |
2006-08-22 |
Scimed Life Systems, Inc. |
Processes for manufacturing polymeric microspheres
|
US8226629B1
(en)
|
2002-04-01 |
2012-07-24 |
Ekos Corporation |
Ultrasonic catheter power control
|
DE10214983A1
(de)
*
|
2002-04-04 |
2004-04-08 |
TransMIT Gesellschaft für Technologietransfer mbH |
Vernebelbare Liposomen und ihre Verwendung zur pulmonalen Applikation von Wirkstoffen
|
US7923029B2
(en)
*
|
2002-04-11 |
2011-04-12 |
Medimmune Llc |
Spray freeze dry of compositions for pulmonary administration
|
US20040042972A1
(en)
*
|
2002-04-11 |
2004-03-04 |
Medimmune Vaccines, Inc. |
Spray freeze dry of compositions for intranasal administration
|
US8829198B2
(en)
*
|
2007-10-31 |
2014-09-09 |
Proteotech Inc |
Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies
|
US20050152962A1
(en)
*
|
2002-06-12 |
2005-07-14 |
Metselaar Josbert M. |
Composition for treatment of inflammatory disorders
|
EP1371362A1
(de)
*
|
2002-06-12 |
2003-12-17 |
Universiteit Utrecht Holding B.V. |
Zusammensetzung zur Behandlung entzündlicher Erkrankungen
|
AU2003240000A1
(en)
|
2002-06-12 |
2003-12-31 |
Boston Scientific Limited |
Bulking agents
|
EP1517684B1
(de)
|
2002-06-27 |
2009-07-22 |
Health Research, Inc. |
Fluorinierte chlorin und bacteriochlorin photosensitizer für fotodynamische therapie
|
WO2004005289A2
(en)
*
|
2002-07-02 |
2004-01-15 |
Health Research, Inc. |
Efficient synthesis of pyropheophorbide a and its derivatives
|
US20040076582A1
(en)
*
|
2002-08-30 |
2004-04-22 |
Dimatteo Kristian |
Agent delivery particle
|
US7842377B2
(en)
|
2003-08-08 |
2010-11-30 |
Boston Scientific Scimed, Inc. |
Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
|
EP1393720A1
(de)
*
|
2002-08-27 |
2004-03-03 |
Universiteit Utrecht |
Vesikel enthaltend Corticosteroide zur Behandlung von Krebs
|
US8012454B2
(en)
|
2002-08-30 |
2011-09-06 |
Boston Scientific Scimed, Inc. |
Embolization
|
AU2003275103A1
(en)
*
|
2002-09-17 |
2004-04-08 |
Diffusion Science, Inc. |
Electrochemical generation, storage and reaction of hydrogen and oxygen using gas permeable catalyst-coated hollow microspheres
|
US6921371B2
(en)
|
2002-10-14 |
2005-07-26 |
Ekos Corporation |
Ultrasound radiating members for catheter
|
US7883490B2
(en)
|
2002-10-23 |
2011-02-08 |
Boston Scientific Scimed, Inc. |
Mixing and delivery of therapeutic compositions
|
US20060036158A1
(en)
|
2003-11-17 |
2006-02-16 |
Inrad, Inc. |
Self-contained, self-piercing, side-expelling marking apparatus
|
JP2006514954A
(ja)
*
|
2002-12-31 |
2006-05-18 |
ネクター セラピューティクス |
抗体含有粒子及び組成物
|
SI2949658T1
(sl)
|
2003-03-03 |
2018-10-30 |
Dyax Corp. |
Peptidi, ki specifično vežejo HGF receptor (cMet) in njihove uporabe
|
US20040258761A1
(en)
*
|
2003-03-20 |
2004-12-23 |
Wheatley Margaret A. |
Polymer-based microcapsules and nanocapsules for diagnostic imaging and drug delivery and methods for their production
|
US20060198882A1
(en)
*
|
2003-03-21 |
2006-09-07 |
Yechezkel Barenholz |
Stable liposomes or micelles comprising a sphinolipid and a peg-lipopolymer
|
US20040248877A1
(en)
*
|
2003-04-30 |
2004-12-09 |
Sandeep Gupta |
Polycyclic diazodioxide-based Bcl-2 protein antagonists and use thereof
|
US20040242886A1
(en)
*
|
2003-04-30 |
2004-12-02 |
Sandeep Gupta |
Monocyclic diazodioxide based Bcl-2 protein antagonists related applications
|
BRPI0410348A
(pt)
*
|
2003-05-14 |
2006-05-30 |
Torreypines Therapeutics Inc |
compostos e usos dos mesmos na modulação de amilóide-beta
|
US7877133B2
(en)
|
2003-05-23 |
2011-01-25 |
Senorx, Inc. |
Marker or filler forming fluid
|
WO2004110963A2
(en)
*
|
2003-05-29 |
2004-12-23 |
Pettegrew Jay W |
Glycerophosphocholine and its derivatives for medical imaging neuropsychiatric disorders
|
US20060257842A1
(en)
*
|
2003-05-29 |
2006-11-16 |
Pettegrew Jay W |
Cryopreservation media and molecules
|
US20090227647A1
(en)
*
|
2008-03-05 |
2009-09-10 |
Thomas Lake |
Compounds, Compositions and Methods for the Treatment of Islet Amyloid Polypeptide (IAPP) Accumulation in Diabetes
|
US20100331380A1
(en)
*
|
2009-06-29 |
2010-12-30 |
Esposito Luke A |
Compounds, Compositions, and Methods for the Treatment of Beta-Amyloid Diseases and Synucleinopathies
|
US8916598B2
(en)
|
2003-05-30 |
2014-12-23 |
Proteotech Inc |
Compounds, compositions, and methods for the treatment of β-amyloid diseases and synucleinopathies
|
US7057100B2
(en)
*
|
2003-06-26 |
2006-06-06 |
The J.C. Robinson Seed Co. |
Inbred corn line W23129
|
US7358226B2
(en)
*
|
2003-08-27 |
2008-04-15 |
The Regents Of The University Of California |
Ultrasonic concentration of drug delivery capsules
|
US7976823B2
(en)
|
2003-08-29 |
2011-07-12 |
Boston Scientific Scimed, Inc. |
Ferromagnetic particles and methods
|
US20050106101A1
(en)
*
|
2003-10-31 |
2005-05-19 |
Ajay Purohit |
Novel chemical agents comprising an adenosine moiety or an adenosine analog moiety and an imaging moiety and methods of their use
|
US7901770B2
(en)
|
2003-11-04 |
2011-03-08 |
Boston Scientific Scimed, Inc. |
Embolic compositions
|
US20050273002A1
(en)
|
2004-06-04 |
2005-12-08 |
Goosen Ryan L |
Multi-mode imaging marker
|
US20080287560A1
(en)
*
|
2004-12-31 |
2008-11-20 |
Loh Roland R |
Polymer foams containing multi-functional layered nano-graphite
|
US9359481B2
(en)
|
2003-11-26 |
2016-06-07 |
Owens Corning Intellectual Capital, Llc |
Thermoplastic foams and method of forming them using nano-graphite
|
US8568632B2
(en)
*
|
2003-11-26 |
2013-10-29 |
Owens Corning Intellectual Capital, Llc |
Method of forming thermoplastic foams using nano-particles to control cell morphology
|
US20110040171A1
(en)
|
2003-12-16 |
2011-02-17 |
University Of Washington |
Image guided high intensity focused ultrasound treatment of nerves
|
JP5247031B2
(ja)
|
2004-01-22 |
2013-07-24 |
ユニバーシティー・オブ・マイアミ |
局所用コエンザイムq10製剤
|
US7201737B2
(en)
|
2004-01-29 |
2007-04-10 |
Ekos Corporation |
Treatment of vascular occlusions using elevated temperatures
|
US7341569B2
(en)
*
|
2004-01-30 |
2008-03-11 |
Ekos Corporation |
Treatment of vascular occlusions using ultrasonic energy and microbubbles
|
WO2005090370A1
(en)
*
|
2004-02-05 |
2005-09-29 |
The Regents Of The University Of California |
Pharmacologically active agents containing esterified phosphonates and methods for use thereof
|
US7736671B2
(en)
|
2004-03-02 |
2010-06-15 |
Boston Scientific Scimed, Inc. |
Embolization
|
US8173176B2
(en)
|
2004-03-30 |
2012-05-08 |
Boston Scientific Scimed, Inc. |
Embolization
|
US7485283B2
(en)
|
2004-04-28 |
2009-02-03 |
Lantheus Medical Imaging |
Contrast agents for myocardial perfusion imaging
|
EP1755585A4
(de)
|
2004-05-20 |
2009-04-01 |
Scripps Research Inst |
Transthyretin-stabilisierung
|
US7311861B2
(en)
|
2004-06-01 |
2007-12-25 |
Boston Scientific Scimed, Inc. |
Embolization
|
US8012457B2
(en)
|
2004-06-04 |
2011-09-06 |
Acusphere, Inc. |
Ultrasound contrast agent dosage formulation
|
US7306716B2
(en)
*
|
2004-06-16 |
2007-12-11 |
Access Business Group International Llc |
Water treatment system
|
WO2006009876A2
(en)
*
|
2004-06-17 |
2006-01-26 |
Cengent Therapeutics, Inc. |
Trisubstituted nitrogen modulators of tyrosine phosphatases
|
JP2008505916A
(ja)
*
|
2004-07-09 |
2008-02-28 |
メタバシス・セラピューティクス・インコーポレイテッド |
チロシンホスファターゼの酸素/窒素複素環阻害剤
|
US9066679B2
(en)
|
2004-08-31 |
2015-06-30 |
University Of Washington |
Ultrasonic technique for assessing wall vibrations in stenosed blood vessels
|
WO2006028970A1
(en)
*
|
2004-09-02 |
2006-03-16 |
Cengent Therapeutics, Inc. |
Derivatives of thiazole and thiadiazole inhibitors of tyrosine phosphatases
|
EP1793919A4
(de)
*
|
2004-09-03 |
2009-12-23 |
Imarx Therapeutics Inc |
Vorrichtung und verfahren zur herstellung einer mikrosphärenbildenden zusammensetzung
|
US8611189B2
(en)
*
|
2004-09-16 |
2013-12-17 |
University of Washington Center for Commercialization |
Acoustic coupler using an independent water pillow with circulation for cooling a transducer
|
NZ584773A
(en)
|
2004-09-17 |
2012-07-27 |
Whitehead Biomedical Inst |
Compounds, Compositions and Methods of Inhibiting Alpha-Synuclein Toxicity
|
US20060067889A1
(en)
*
|
2004-09-27 |
2006-03-30 |
Light Sciences Corporation |
Singlet oxygen photosensitizers activated by target binding enhancing the selectivity of targeted PDT agents
|
JP2008515929A
(ja)
*
|
2004-10-08 |
2008-05-15 |
アルザ コーポレイション |
脂質連結部分を予備形成した脂質集合体にマイクロ波を使用して挿入する方法
|
US8425550B2
(en)
|
2004-12-01 |
2013-04-23 |
Boston Scientific Scimed, Inc. |
Embolic coils
|
PT2727583T
(pt)
|
2004-12-22 |
2021-12-27 |
Nitto Denko Corp |
Veículo de fármaco e kit de veículo de fármaco para a inibição da fibrose
|
US20120269886A1
(en)
|
2004-12-22 |
2012-10-25 |
Nitto Denko Corporation |
Therapeutic agent for pulmonary fibrosis
|
CN100427142C
(zh)
*
|
2005-01-10 |
2008-10-22 |
重庆海扶(Hifu)技术有限公司 |
一种高强度聚焦超声治疗用助剂及其筛选方法
|
ES2375267T3
(es)
*
|
2005-01-28 |
2012-02-28 |
North-West University |
Combinación de lípidos y de óxido nitroso como adyuvante para potenciar de la eficacia de vacunas.
|
US7727555B2
(en)
|
2005-03-02 |
2010-06-01 |
Boston Scientific Scimed, Inc. |
Particles
|
US7858183B2
(en)
|
2005-03-02 |
2010-12-28 |
Boston Scientific Scimed, Inc. |
Particles
|
US8153435B1
(en)
|
2005-03-30 |
2012-04-10 |
Tracer Detection Technology Corp. |
Methods and articles for identifying objects using encapsulated perfluorocarbon tracers
|
WO2006130217A2
(en)
*
|
2005-04-01 |
2006-12-07 |
The Regents Of The University Of California |
Substituted phosphate esters of nucleoside phosphonates
|
ATE534652T1
(de)
|
2005-04-01 |
2011-12-15 |
Univ California |
Phosphono-pent-2-en-1-yl-nukleoside und analoga
|
US20060264809A1
(en)
*
|
2005-04-12 |
2006-11-23 |
Hansmann Douglas R |
Ultrasound catheter with cavitation promoting surface
|
EP1714642A1
(de)
*
|
2005-04-18 |
2006-10-25 |
Bracco Research S.A. |
Pharmazeutische Formulierung mit gasgefüllten Mikrokapseln zur ultraschallgesteuerten Freisetzung
|
US10357328B2
(en)
|
2005-04-20 |
2019-07-23 |
Bard Peripheral Vascular, Inc. and Bard Shannon Limited |
Marking device with retractable cannula
|
US7963287B2
(en)
|
2005-04-28 |
2011-06-21 |
Boston Scientific Scimed, Inc. |
Tissue-treatment methods
|
AU2005332157A1
(en)
*
|
2005-05-23 |
2006-11-30 |
Mebiopharm Co., Ltd., |
Method of producing liposomes containing gas enclosed therein
|
US20090221902A1
(en)
*
|
2005-06-02 |
2009-09-03 |
Cancercure Technology As |
Ultrasound Treatment Center
|
WO2007002109A2
(en)
*
|
2005-06-20 |
2007-01-04 |
The Regents Of The University Of California |
Multidentate pyrone-derived chelators for medicinal imaging and chelation
|
US9463426B2
(en)
|
2005-06-24 |
2016-10-11 |
Boston Scientific Scimed, Inc. |
Methods and systems for coating particles
|
US7824659B2
(en)
|
2005-08-10 |
2010-11-02 |
Lantheus Medical Imaging, Inc. |
Methods of making radiolabeled tracers and precursors thereof
|
WO2007021958A2
(en)
|
2005-08-12 |
2007-02-22 |
University Of Washington |
Method and apparatus for preparing organs and tissues for laparoscopic surgery
|
US9486274B2
(en)
|
2005-09-07 |
2016-11-08 |
Ulthera, Inc. |
Dissection handpiece and method for reducing the appearance of cellulite
|
US8518069B2
(en)
|
2005-09-07 |
2013-08-27 |
Cabochon Aesthetics, Inc. |
Dissection handpiece and method for reducing the appearance of cellulite
|
US9358033B2
(en)
|
2005-09-07 |
2016-06-07 |
Ulthera, Inc. |
Fluid-jet dissection system and method for reducing the appearance of cellulite
|
US9011473B2
(en)
|
2005-09-07 |
2015-04-21 |
Ulthera, Inc. |
Dissection handpiece and method for reducing the appearance of cellulite
|
US10548659B2
(en)
|
2006-01-17 |
2020-02-04 |
Ulthera, Inc. |
High pressure pre-burst for improved fluid delivery
|
US9187608B2
(en)
*
|
2005-09-08 |
2015-11-17 |
Owens Corning Intellectual Capital, Llc |
Polystyrene foam containing a modifier-free nanoclay and having improved fire protection performance
|
US8414494B2
(en)
|
2005-09-16 |
2013-04-09 |
University Of Washington |
Thin-profile therapeutic ultrasound applicators
|
US8492428B2
(en)
*
|
2005-09-20 |
2013-07-23 |
Mayo Foundation For Medical Education And Research |
Small-molecule botulinum toxin inhibitors
|
US8016757B2
(en)
|
2005-09-30 |
2011-09-13 |
University Of Washington |
Non-invasive temperature estimation technique for HIFU therapy monitoring using backscattered ultrasound
|
CA2562580C
(en)
|
2005-10-07 |
2014-04-29 |
Inrad, Inc. |
Drug-eluting tissue marker
|
US8007509B2
(en)
|
2005-10-12 |
2011-08-30 |
Boston Scientific Scimed, Inc. |
Coil assemblies, components and methods
|
US8167805B2
(en)
|
2005-10-20 |
2012-05-01 |
Kona Medical, Inc. |
Systems and methods for ultrasound applicator station keeping
|
US8257338B2
(en)
*
|
2006-10-27 |
2012-09-04 |
Artenga, Inc. |
Medical microbubble generation
|
US7885793B2
(en)
|
2007-05-22 |
2011-02-08 |
International Business Machines Corporation |
Method and system for developing a conceptual model to facilitate generating a business-aligned information technology solution
|
US20080195036A1
(en)
*
|
2005-12-02 |
2008-08-14 |
Cabochon Aesthetics, Inc. |
Devices and methods for selectively lysing cells
|
US20080014627A1
(en)
*
|
2005-12-02 |
2008-01-17 |
Cabochon Aesthetics, Inc. |
Devices and methods for selectively lysing cells
|
US20080200864A1
(en)
*
|
2005-12-02 |
2008-08-21 |
Cabochon Aesthetics, Inc. |
Devices and methods for selectively lysing cells
|
US9248317B2
(en)
*
|
2005-12-02 |
2016-02-02 |
Ulthera, Inc. |
Devices and methods for selectively lysing cells
|
US20070140973A1
(en)
*
|
2005-12-15 |
2007-06-21 |
Bristol-Myers Squibb Pharma Company |
Contrast agents for myocardium perfusion imaging
|
US8101197B2
(en)
|
2005-12-19 |
2012-01-24 |
Stryker Corporation |
Forming coils
|
US8152839B2
(en)
|
2005-12-19 |
2012-04-10 |
Boston Scientific Scimed, Inc. |
Embolic coils
|
US7947368B2
(en)
|
2005-12-21 |
2011-05-24 |
Boston Scientific Scimed, Inc. |
Block copolymer particles
|
US9572886B2
(en)
|
2005-12-22 |
2017-02-21 |
Nitto Denko Corporation |
Agent for treating myelofibrosis
|
US8138361B2
(en)
*
|
2005-12-28 |
2012-03-20 |
The Trustees Of The University Of Pennsylvania |
C-10 carbamates of taxanes
|
US20070196462A1
(en)
*
|
2006-01-24 |
2007-08-23 |
Imarx Therapeutics, Inc. |
Composition and method for neuromuscular blockade
|
US20070184085A1
(en)
*
|
2006-02-03 |
2007-08-09 |
Boston Scientific Scimed, Inc. |
Ultrasound activated medical device
|
US20070184076A1
(en)
*
|
2006-02-07 |
2007-08-09 |
Unger Evan C |
Liquid-filled nanodroplets for anti-cancer therapy
|
DK2383271T3
(da)
*
|
2006-03-13 |
2013-10-07 |
Kyorin Seiyaku Kk |
Aminoquinoloner som GSK-3-inhibitorer
|
EP2007373A4
(de)
*
|
2006-03-29 |
2012-12-19 |
Foldrx Pharmaceuticals Inc |
Hemmung der alpha-synuclein-toxizität
|
EP2015846A2
(de)
|
2006-04-24 |
2009-01-21 |
Ekos Corporation |
Ultraschalltherapiesystem
|
WO2007127958A2
(en)
*
|
2006-04-27 |
2007-11-08 |
Barnes-Jewish Hospital |
Detection and imaging of target tissue
|
WO2007137236A2
(en)
*
|
2006-05-19 |
2007-11-29 |
Drexel University |
Drug loaded contrast agents: combining diagnosis and therapy
|
DK2484696T3
(en)
|
2006-08-28 |
2017-10-02 |
Kyowa Hakko Kirin Co Ltd |
Antagonistic hLIGHT-specific human monoclonal antibodies
|
US20070080613A1
(en)
*
|
2006-09-20 |
2007-04-12 |
Sterlite Optical Technologies Ltd |
Storage and transportation device for storing and transporting optical fiber preform and precursors thereof
|
PT2066662E
(pt)
|
2006-09-21 |
2013-02-13 |
Kyorin Seiyaku Kk |
Inibidores de serina-hidrolase
|
JP2010507585A
(ja)
|
2006-10-19 |
2010-03-11 |
オースペックス・ファーマシューティカルズ・インコーポレイテッド |
置換インドール
|
ES2443526T3
(es)
|
2006-10-23 |
2014-02-19 |
C.R. Bard, Inc. |
Marcador mamario
|
US8414927B2
(en)
|
2006-11-03 |
2013-04-09 |
Boston Scientific Scimed, Inc. |
Cross-linked polymer particles
|
WO2008057604A2
(en)
*
|
2006-11-08 |
2008-05-15 |
The Regents Of The University Of California |
Small molecule therapeutics, syntheses of analogues and derivatives and methods of use
|
EP3542748B1
(de)
|
2006-12-12 |
2023-08-16 |
C. R. Bard, Inc. |
Gewebemarker mit mehreren bildgebungsmodi
|
US8401622B2
(en)
|
2006-12-18 |
2013-03-19 |
C. R. Bard, Inc. |
Biopsy marker with in situ-generated imaging properties
|
US20080146605A1
(en)
|
2006-12-19 |
2008-06-19 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of ccr5 inhibitors
|
CA2671766A1
(en)
*
|
2006-12-22 |
2008-07-03 |
Encysive Pharmaceuticals, Inc. |
Modulators of c3a receptor and methods of use thereof
|
US10182833B2
(en)
|
2007-01-08 |
2019-01-22 |
Ekos Corporation |
Power parameters for ultrasonic catheter
|
ATE525068T1
(de)
*
|
2007-02-28 |
2011-10-15 |
Conatus Pharmaceuticals Inc |
Verfahren zur behandlung von chronischer viraler hepatitis c mithilfe von ro 113-0830
|
WO2008106167A1
(en)
*
|
2007-02-28 |
2008-09-04 |
Conatus Pharmaceuticals, Inc. |
Combination therapy comprising matrix metalloproteinase inhibitors and caspase inhibitors for the treatment of liver diseases
|
SI2125698T1
(sl)
|
2007-03-15 |
2016-12-30 |
Auspex Pharmaceuticals, Inc. |
Devterirani d9-venlafaksin
|
AU2008228764B2
(en)
|
2007-03-22 |
2014-05-08 |
Berg Llc |
Topical formulations having enhanced bioavailability
|
US20080242752A1
(en)
*
|
2007-03-28 |
2008-10-02 |
Yadollah Delaviz |
Polystyrene foams incorporating nanographite and HFC-134
|
TWI407971B
(zh)
*
|
2007-03-30 |
2013-09-11 |
Nitto Denko Corp |
Cancer cells and tumor-related fibroblasts
|
WO2008128115A2
(en)
*
|
2007-04-13 |
2008-10-23 |
Somaxon Pharmaceuticals, Inc. |
Low-dose doxepin formulations
|
US7892776B2
(en)
|
2007-05-04 |
2011-02-22 |
The Regents Of The University Of California |
Screening assay to identify modulators of protein kinase A
|
EP2494932B1
(de)
|
2007-06-22 |
2020-05-20 |
Ekos Corporation |
Vorrichtung zur Behandlung von intrakranialen Blutungen
|
BRPI0814542A2
(pt)
*
|
2007-07-12 |
2014-09-30 |
Tragara Pharmaceuticals Inc |
Métodos e composições para o tratamento de câncer, tumores e desordens relacionadas a tumores
|
MX2010002667A
(es)
*
|
2007-09-11 |
2010-04-01 |
Activx Biosciences Inc |
Cianoaminoquinolonas y tetrazoloaminoquinolonas como inhibidores de gsk-3.
|
MX2010002662A
(es)
|
2007-09-12 |
2010-04-09 |
Activx Biosciences Inc |
Aminoquinolonas espirociclicas como inhibidores de gsk-3.
|
US20090264421A1
(en)
*
|
2007-10-05 |
2009-10-22 |
Bible Keith C |
Methods and Compositions for Treating Cancer
|
US8439940B2
(en)
|
2010-12-22 |
2013-05-14 |
Cabochon Aesthetics, Inc. |
Dissection handpiece with aspiration means for reducing the appearance of cellulite
|
SG186008A1
(en)
*
|
2007-11-21 |
2012-12-28 |
Pharmaxis Ltd |
Haloallylamine inhibitors of ssao/vap-1 and uses therefor
|
EP2222279A2
(de)
*
|
2007-12-10 |
2010-09-01 |
Epitarget AS |
Akustisch empfindliche arzneiabgabepartikel mit nichtlamellar formenden lipiden
|
US20090151241A1
(en)
*
|
2007-12-14 |
2009-06-18 |
Dressler Lawrence V |
Method for producing algae in photobioreactor
|
US8311610B2
(en)
|
2008-01-31 |
2012-11-13 |
C. R. Bard, Inc. |
Biopsy tissue marker
|
EP2257315B1
(de)
|
2008-02-29 |
2019-10-23 |
Lantheus Medical Imaging, Inc. |
Kontrastmittel für anwendungen einschliesslich perfusionsbildgebung
|
MY161576A
(en)
|
2008-03-17 |
2017-04-28 |
Ambit Biosciences Corp |
Quinazoline derivatives as raf kinase modulators and methods of use thereof
|
EP3015104A1
(de)
|
2008-04-11 |
2016-05-04 |
Berg LLC |
Verfahren und verwendung zur einleitung von apoptose bei krebszellen
|
US8197857B2
(en)
*
|
2008-06-06 |
2012-06-12 |
Dressler Lawrence V |
Method for eliminating carbon dioxide from waste gases
|
GB0811856D0
(en)
|
2008-06-27 |
2008-07-30 |
Ucl Business Plc |
Magnetic microbubbles, methods of preparing them and their uses
|
US20120034155A1
(en)
*
|
2010-08-03 |
2012-02-09 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Artificial cells
|
CN101658533A
(zh)
*
|
2008-08-29 |
2010-03-03 |
首都医科大学宣武医院 |
抗肿瘤药物的干细胞递送
|
US9327061B2
(en)
|
2008-09-23 |
2016-05-03 |
Senorx, Inc. |
Porous bioabsorbable implant
|
WO2010040772A2
(en)
*
|
2008-10-07 |
2010-04-15 |
Bracco Research Sa |
Targeting construct comprising anti-polymer antibody and liposomes or microvesicles binding to the same
|
CA2742765C
(en)
|
2008-12-30 |
2016-04-12 |
C.R. Bard Inc. |
Marker delivery device for tissue marker placement
|
WO2010088450A2
(en)
|
2009-01-30 |
2010-08-05 |
Celladon Corporation |
Methods for treating diseases associated with the modulation of serca
|
US20100204570A1
(en)
*
|
2009-02-06 |
2010-08-12 |
Paul Lubock |
Anchor markers
|
US8568793B2
(en)
|
2009-02-11 |
2013-10-29 |
Hope Medical Enterprises, Inc. |
Sodium nitrite-containing pharmaceutical compositions
|
SI2401267T1
(sl)
|
2009-02-27 |
2014-05-30 |
Ambit Biosciences Corporation |
Derivati kinazolina, ki modulirajo JAK-kinazo, in njihova uporaba v postopkih
|
EP2403860B1
(de)
|
2009-03-04 |
2015-11-04 |
IDENIX Pharmaceuticals, Inc. |
Phosphothiophene und phosphothiazole als hcv polymerase inhibitoren
|
CN102421784B
(zh)
*
|
2009-03-11 |
2015-09-30 |
杏林制药株式会社 |
作为gsk-3抑制剂的7-环烷基氨基喹诺酮
|
WO2010105016A1
(en)
|
2009-03-11 |
2010-09-16 |
Ambit Biosciences Corp. |
Combination of an indazolylaminopyrrolotriazine and taxane for cancer treatment
|
EP3138603A1
(de)
*
|
2009-03-20 |
2017-03-08 |
Incube Labs, Llc |
Feststoffverabreichungsvorrichtung, formulierungen und verfahren zur verwendung
|
SG174527A1
(en)
|
2009-03-27 |
2011-11-28 |
Pathway Therapeutics Inc |
Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
|
WO2010110686A1
(en)
|
2009-03-27 |
2010-09-30 |
Pathway Therapeutics Limited |
Pyrimidinyl and 1,3,5 triazinyl benzimidazoles and their use in cancer therapy
|
WO2010120368A2
(en)
|
2009-04-15 |
2010-10-21 |
Lantheus Medical Imaging, Inc. |
Stabilization of radiopharmaceutical compositions using ascorbic acid
|
PE20120811A1
(es)
|
2009-04-22 |
2012-07-08 |
Axikin Pharmaceuticals Inc |
Antagonistas ccr3 arilsulfonamida
|
EP2421829B1
(de)
|
2009-04-22 |
2015-09-30 |
Axikin Pharmaceuticals, Inc. |
2,5-disubstituierte arylsulfonamide als ccr3-antagonisten
|
ES2664984T3
(es)
|
2009-04-22 |
2018-04-24 |
SMA Therapeutics, Inc. |
Arilsulfonamidas 2,5-disustituidas antagonistas de CCR3
|
CN104825429A
(zh)
|
2009-05-11 |
2015-08-12 |
博格有限责任公司 |
利用表观代谢转变剂(辅酶q10)治疗疾病的方法
|
DE102009031274A1
(de)
|
2009-06-30 |
2011-01-13 |
Justus-Liebig-Universität Giessen |
Liposomen zur pulmonalen Applikation
|
WO2011003870A2
(en)
|
2009-07-06 |
2011-01-13 |
Creabilis S.A. |
Mini-pegylated corticosteroids, compositions including same, and methods of making and using same
|
US8486939B2
(en)
|
2009-07-07 |
2013-07-16 |
Pathway Therapeutics Inc. |
Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy
|
HUE035519T2
(en)
|
2009-07-08 |
2018-05-02 |
Hope Medical Entpr Inc D B A Hope Pharmaceuticals |
Sodium thiosulfate-containing pharmaceutical composition
|
US8404728B2
(en)
|
2009-07-30 |
2013-03-26 |
Mayo Foundation For Medical Education And Research |
Small-molecule botulinum toxin inhibitors
|
WO2011017389A1
(en)
|
2009-08-05 |
2011-02-10 |
Idenix Pharmaceuticals, Inc. |
Macrocyclic serine protease inhibitors useful against viral infections, particularly hcv
|
US11096708B2
(en)
|
2009-08-07 |
2021-08-24 |
Ulthera, Inc. |
Devices and methods for performing subcutaneous surgery
|
US9358064B2
(en)
|
2009-08-07 |
2016-06-07 |
Ulthera, Inc. |
Handpiece and methods for performing subcutaneous surgery
|
KR20120059558A
(ko)
|
2009-08-19 |
2012-06-08 |
암비트 바이오사이언시즈 코포레이션 |
바이아릴 화합물 및 이의 사용 방법
|
WO2011029094A2
(en)
|
2009-09-04 |
2011-03-10 |
The University Of North Carolina At Chapel Hill |
Systems, methods, and computer readable media for high- frequency contrast imaging and image-guided therapeutics
|
EP2477550A4
(de)
*
|
2009-09-15 |
2013-12-04 |
Univ Columbia |
Systeme, verfahren und vorrichtungen für mikrobläschen
|
US20110092880A1
(en)
|
2009-10-12 |
2011-04-21 |
Michael Gertner |
Energetic modulation of nerves
|
US20110118600A1
(en)
|
2009-11-16 |
2011-05-19 |
Michael Gertner |
External Autonomic Modulation
|
US9174065B2
(en)
|
2009-10-12 |
2015-11-03 |
Kona Medical, Inc. |
Energetic modulation of nerves
|
US9119951B2
(en)
|
2009-10-12 |
2015-09-01 |
Kona Medical, Inc. |
Energetic modulation of nerves
|
US8295912B2
(en)
|
2009-10-12 |
2012-10-23 |
Kona Medical, Inc. |
Method and system to inhibit a function of a nerve traveling with an artery
|
US8469904B2
(en)
|
2009-10-12 |
2013-06-25 |
Kona Medical, Inc. |
Energetic modulation of nerves
|
US20160059044A1
(en)
|
2009-10-12 |
2016-03-03 |
Kona Medical, Inc. |
Energy delivery to intraparenchymal regions of the kidney to treat hypertension
|
US8986211B2
(en)
|
2009-10-12 |
2015-03-24 |
Kona Medical, Inc. |
Energetic modulation of nerves
|
US8517962B2
(en)
|
2009-10-12 |
2013-08-27 |
Kona Medical, Inc. |
Energetic modulation of nerves
|
US8986231B2
(en)
|
2009-10-12 |
2015-03-24 |
Kona Medical, Inc. |
Energetic modulation of nerves
|
TW201120037A
(en)
*
|
2009-10-26 |
2011-06-16 |
Sunesis Pharmaceuticals Inc |
Compounds and methods for treatment of cancer
|
WO2011056764A1
(en)
|
2009-11-05 |
2011-05-12 |
Ambit Biosciences Corp. |
Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles
|
EP2499282B1
(de)
|
2009-11-09 |
2015-04-22 |
NeuroGenetic Pharmaceuticals, Inc. |
Gamma-sekretase-modulierende verbindungen, verfahren zu ihrer identifikation und verwendungen dafür
|
WO2011069002A1
(en)
|
2009-12-02 |
2011-06-09 |
Alquest Therapeutics, Inc. |
Organoselenium compounds and uses thereof
|
MX2012006877A
(es)
|
2009-12-18 |
2012-08-31 |
Idenix Pharmaceuticals Inc |
Inhibidores de virus de hepatitis c de arileno o heteroarileno 5, 5 - fusionado.
|
SG181896A1
(en)
*
|
2009-12-23 |
2012-07-30 |
Map Pharmaceuticals Inc |
Novel ergoline analogs
|
WO2011094890A1
(en)
|
2010-02-02 |
2011-08-11 |
Argusina Inc. |
Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
|
KR20170033873A
(ko)
|
2010-02-08 |
2017-03-27 |
랜티우스 메디컬 이메징, 인크. |
조영제 및 이의 중간체를 합성하는 방법 및 장치
|
WO2011109345A1
(en)
|
2010-03-02 |
2011-09-09 |
Axikin Pharmaceuticals, Inc. |
Isotopically enriched arylsulfonamide ccr3 antagonists
|
WO2011112689A2
(en)
|
2010-03-11 |
2011-09-15 |
Ambit Biosciences Corp. |
Saltz of an indazolylpyrrolotriazine
|
NZ701451A
(en)
*
|
2010-03-12 |
2016-09-30 |
Berg Llc |
Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof
|
AU2011227232B2
(en)
|
2010-03-17 |
2015-07-09 |
Axikin Pharmaceuticals Inc. |
Arylsulfonamide CCR3 antagonists
|
CN102834068B
(zh)
*
|
2010-04-09 |
2015-11-25 |
株式会社日立制作所 |
超声波诊断治疗装置
|
WO2011150198A1
(en)
|
2010-05-27 |
2011-12-01 |
Ambit Biosciences Corporation |
Azolyl urea compounds and methods of use thereof
|
WO2011150201A2
(en)
|
2010-05-27 |
2011-12-01 |
Ambit Biosciences Corporation |
Azolyl amide compounds and methods of use thereof
|
CN103153309A
(zh)
|
2010-06-01 |
2013-06-12 |
拜欧赛里克斯公司 |
使用6-环己基-1-羟基-4-甲基-2(1h)-吡啶酮治疗血液恶性肿瘤的方法
|
CN104926722A
(zh)
|
2010-06-01 |
2015-09-23 |
拜欧赛里克斯公司 |
羟基吡啶酮衍生物、其药物组合物及其用于治疗增生性疾病的治疗用途
|
CN104860907A
(zh)
|
2010-06-07 |
2015-08-26 |
诺沃梅迪科斯有限公司 |
呋喃基化合物及其用途
|
EP2595615A1
(de)
|
2010-07-19 |
2013-05-29 |
Summa Health System |
Vitamin c und chromfreies vitamin k sowie zusammensetzungen daraus zur behandlung von nfkb-induzierten leiden oder erkrankungen
|
ITPI20100095A1
(it)
*
|
2010-07-28 |
2012-01-29 |
Giuseppe Sabino |
Un mezzo di contrasto ecografico antigene-specifico, un procedimento per la sua preparazione e suoi usi.
|
EP2611792B1
(de)
|
2010-09-01 |
2017-02-01 |
Ambit Biosciences Corporation |
Hydrobromid salze einer pyrazolylaminoquinazolin
|
WO2012030912A1
(en)
|
2010-09-01 |
2012-03-08 |
Ambit Biosciences Corporation |
7-cyclylquinazoline derivatives and methods of use thereof
|
US20130303533A1
(en)
|
2010-09-01 |
2013-11-14 |
Ambit Biosciences Corporation |
Azolopyridine and azolopyrimidine compounds and methods of use thereof
|
US20130225614A1
(en)
|
2010-09-01 |
2013-08-29 |
Ambit Biosciences Corporation |
4-azolylaminoquinazoline derivatives and methods of use thereof
|
MX2013002384A
(es)
|
2010-09-01 |
2013-07-05 |
Ambit Biosciences Corp |
Compuestos quinazolina y metodos para utilizarlos.
|
EP2611793A1
(de)
|
2010-09-01 |
2013-07-10 |
Ambit Biosciences Corporation |
2-cyclochinazolinderivate und verwendungsverfahren dafür
|
WO2012030944A2
(en)
|
2010-09-01 |
2012-03-08 |
Ambit Biosciences Corporation |
Quinoline and isoquinoline compounds and methods of use thereof
|
CA2809994A1
(en)
|
2010-09-01 |
2012-03-08 |
Ambit Biosciences Corporation |
An optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof
|
EP2611812A1
(de)
|
2010-09-01 |
2013-07-10 |
Ambit Biosciences Corporation |
Thienopyridin- und thienopyrimidinverbindungen sowie verfahren zu ihrer verwendung
|
WO2012030918A1
(en)
|
2010-09-01 |
2012-03-08 |
Ambit Biosciences Corporation |
Adenosine a3 receptor modulating compounds and methods of use thereof
|
WO2012044641A1
(en)
|
2010-09-29 |
2012-04-05 |
Pathway Therapeutics Inc. |
1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
|
US9427410B2
(en)
|
2010-10-08 |
2016-08-30 |
The University Of North Carolina At Chapel Hill |
Formulation of acoustically activatable particles having low vaporization energy and methods for using same
|
US20120088769A1
(en)
|
2010-10-11 |
2012-04-12 |
Axikin Pharmaceuticals, Inc. |
Salts of arylsulfonamide ccr3 antagonists
|
AU2011338530B2
(en)
|
2010-12-06 |
2017-06-15 |
Follica, Inc. |
Methods for treating baldness and promoting hair growth
|
WO2012080050A1
(en)
|
2010-12-14 |
2012-06-21 |
F. Hoffmann-La Roche Ag |
Solid forms of a phenoxybenzenesulfonyl compound
|
WO2012103165A2
(en)
|
2011-01-26 |
2012-08-02 |
Kolltan Pharmaceuticals, Inc. |
Anti-kit antibodies and uses thereof
|
CA2825152A1
(en)
|
2011-01-31 |
2012-08-09 |
Celgene Corporation |
Pharmaceutical compositions of cytidine analogs and methods of use thereof
|
US9353100B2
(en)
|
2011-02-10 |
2016-05-31 |
Idenix Pharmaceuticals Llc |
Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections
|
EP2691388A1
(de)
|
2011-03-28 |
2014-02-05 |
MEI Pharma, Inc. |
(kondensierte arylamino- und heterocyclylamino-)pyrimidynyl und 1,3,5-triazinyl-benzimidazole, pharmazeutische zusammensetzungen daraus und ihre verwendung zur behandlung von proliferativen erkrankungen
|
CA2831590A1
(en)
|
2011-03-28 |
2012-10-04 |
Mei Pharma, Inc. |
(alpha-substituted cycloalkylamino and heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
|
BR112013024907A2
(pt)
|
2011-03-28 |
2016-12-20 |
Mei Pharma Inc |
composto, composição farmacêutica, método para o tratamento, prevenção ou atenuação de um ou mais sintomas de um distúrbio, doença ou condição mediada por pi3k em um sujeito, método para modular a atividade enzimática de pi3k
|
US20120252721A1
(en)
|
2011-03-31 |
2012-10-04 |
Idenix Pharmaceuticals, Inc. |
Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
|
AU2012240222B2
(en)
|
2011-04-04 |
2017-04-27 |
Berg Llc |
Methods of treating central nervous system tumors
|
WO2012136813A2
(en)
|
2011-04-07 |
2012-10-11 |
Universitetet I Oslo |
Agents for medical radar diagnosis
|
CN103732214B
(zh)
|
2011-06-17 |
2017-04-12 |
博格有限责任公司 |
可吸入药物组合物
|
MX2013015373A
(es)
|
2011-06-23 |
2014-02-11 |
Map Pharmaceuticals Inc |
Nuevos analogos de fluoroergolina.
|
WO2013037482A1
(en)
|
2011-09-15 |
2013-03-21 |
Phenex Pharmaceuticals Ag |
Farnesoid x receptor agonists for cancer treatment and prevention
|
US8822549B2
(en)
*
|
2011-10-13 |
2014-09-02 |
Jennifer L. Johnson |
Buffered oxygen therapeutic
|
MX368081B
(es)
|
2011-10-14 |
2019-09-19 |
Ambit Biosciences Corp |
Compuestos heterociclicos y uso de los mismos como moduladores del receptor de tirosina cinasas tipo iii.
|
US9057712B1
(en)
|
2011-10-27 |
2015-06-16 |
Copilot Ventures Fund Iii Llc |
Methods of delivery of encapsulated perfluorocarbon taggants
|
SG11201403434YA
(en)
|
2011-12-19 |
2014-09-26 |
Map Pharmaceuticals Inc |
Novel iso-ergoline derivatives
|
AU2012355983A1
(en)
|
2011-12-21 |
2015-01-22 |
Map Pharmaceuticals, Inc. |
Novel neuromodulatory compounds
|
WO2013130600A1
(en)
|
2012-02-29 |
2013-09-06 |
Ambit Biosciences Corporation |
Solid forms comprising optically active pyrazolylaminoquinazoline, compositions thereof, and uses therewith
|
WO2013138613A1
(en)
|
2012-03-16 |
2013-09-19 |
Axikin Pharmaceuticals, Inc. |
3,5-diaminopyrazole kinase inhibitors
|
LT2844637T
(lt)
|
2012-05-02 |
2018-05-10 |
Boehringer Ingelheim International Gmbh |
Pakeistieji 3-haloalilamino ssao inhibitoriai ir jų panaudojimas
|
EP3406598B1
(de)
|
2012-06-14 |
2020-01-29 |
Mayo Foundation for Medical Education and Research |
Pyrazolderivate als hemmer von stat3
|
US9012640B2
(en)
|
2012-06-22 |
2015-04-21 |
Map Pharmaceuticals, Inc. |
Cabergoline derivatives
|
JP6420761B2
(ja)
*
|
2012-06-26 |
2018-11-07 |
ジーイー・ヘルスケア・アクスイェ・セルスカプ |
気体マイクロバブルを含む組成物の調製
|
DK3381943T3
(da)
|
2012-07-25 |
2022-05-16 |
Celldex Therapeutics Inc |
Anti-kit-antistoffer og anvendelser deraf
|
AU2013203000B9
(en)
|
2012-08-10 |
2017-02-02 |
Lantheus Medical Imaging, Inc. |
Compositions, methods, and systems for the synthesis and use of imaging agents
|
CN110464709A
(zh)
|
2012-08-10 |
2019-11-19 |
德克萨斯州大学系统董事会 |
用于治疗中风的神经保护性脂质体组合物和方法
|
US9074186B2
(en)
|
2012-08-15 |
2015-07-07 |
Boston Medical Center Corporation |
Production of red blood cells and platelets from stem cells
|
TW201414721A
(zh)
|
2012-09-07 |
2014-04-16 |
Axikin Pharmaceuticals Inc |
同位素濃化之芳磺醯胺ccr3拮抗劑
|
WO2014055647A1
(en)
|
2012-10-03 |
2014-04-10 |
Mei Pharma, Inc. |
(sulfinyl and sulfonyl benzimidazolyl) pyrimidines and triazines, pharmaceutical compositions thereof, and their use for treating proliferative diseases
|
US9982290B2
(en)
|
2012-10-04 |
2018-05-29 |
The University Of North Carolina At Chapel Hill |
Methods and systems for using encapsulated microbubbles to process biological samples
|
US20150272924A1
(en)
|
2012-11-08 |
2015-10-01 |
Summa Health System |
Vitamin c, vitamin k, a polyphenol, and combinations thereof for wound healing
|
CN104955801B
(zh)
|
2012-11-30 |
2017-10-31 |
诺沃梅迪科斯有限公司 |
取代的二芳基磺酰胺及其用途
|
US9169214B2
(en)
|
2012-12-21 |
2015-10-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactions
|
BR112015014964A2
(pt)
|
2012-12-21 |
2017-07-11 |
Map Pharmaceuticals Inc |
novos derivados de metisergida
|
EP2943188A1
(de)
|
2013-01-11 |
2015-11-18 |
Mayo Foundation for Medical Education and Research |
Vitamine c und k zur behandlung polyzystischer erkrankungen
|
US9101745B2
(en)
|
2013-03-14 |
2015-08-11 |
Sonogene Llc |
Sonochemical induction of ABCA1 expression and compositions therefor
|
EP2968126B1
(de)
|
2013-03-15 |
2022-04-06 |
The Board of Regents of The University of Texas System |
Edelgasreiche flüssigkeiten sowie verfahren zu deren herstellung und verwendung
|
SG11201508272YA
(en)
|
2013-04-08 |
2015-11-27 |
Berg Llc |
Treatment of cancer using coenzyme q10 combination therapies
|
ES2891755T3
(es)
|
2013-06-06 |
2022-01-31 |
Pf Medicament |
Anticuerpos anti-C10orf54 y utilizaciones de los mismos
|
RU2016111675A
(ru)
|
2013-08-30 |
2017-10-04 |
Эмбит Байосайенсиз Корпорейшн |
Соединения биарилацетамида и способы их применения
|
US9901542B2
(en)
|
2013-09-04 |
2018-02-27 |
Berg Llc |
Methods of treatment of cancer by continuous infusion of coenzyme Q10
|
NZ631142A
(en)
|
2013-09-18 |
2016-03-31 |
Axikin Pharmaceuticals Inc |
Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors
|
EP3046924A1
(de)
|
2013-09-20 |
2016-07-27 |
IDENIX Pharmaceuticals, Inc. |
Inhibitoren des hepatitis-c-virus
|
USD715442S1
(en)
|
2013-09-24 |
2014-10-14 |
C. R. Bard, Inc. |
Tissue marker for intracorporeal site identification
|
USD715942S1
(en)
|
2013-09-24 |
2014-10-21 |
C. R. Bard, Inc. |
Tissue marker for intracorporeal site identification
|
USD716450S1
(en)
|
2013-09-24 |
2014-10-28 |
C. R. Bard, Inc. |
Tissue marker for intracorporeal site identification
|
USD716451S1
(en)
|
2013-09-24 |
2014-10-28 |
C. R. Bard, Inc. |
Tissue marker for intracorporeal site identification
|
US10272117B2
(en)
|
2014-02-24 |
2019-04-30 |
Celgene Corporation |
Methods of using an activator of cereblon for neural cell expansion and the treatment of central nervous system disorders
|
GB201403775D0
(en)
|
2014-03-04 |
2014-04-16 |
Kymab Ltd |
Antibodies, uses & methods
|
US20170066779A1
(en)
|
2014-03-05 |
2017-03-09 |
Idenix Pharmaceuticals Llc |
Solid forms of a flaviviridae virus inhibitor compound and salts thereof
|
KR102409739B1
(ko)
|
2014-03-20 |
2022-06-17 |
카펠라 테라퓨틱스, 인크. |
암 치료용의 erbb 티로신 키나제 억제제로서의 벤즈이미다졸 유도체
|
MX2016012097A
(es)
|
2014-03-20 |
2017-04-27 |
Capella Therapeutics Inc |
Derivados de bencimidazol como inhibidores de tirosina cinasa erbb para el tratamiento del cáncer.
|
US9968758B2
(en)
*
|
2014-03-21 |
2018-05-15 |
Boston Scientific Scimed, Inc. |
Devices and methods for treating a lung
|
ES2751652T3
(es)
|
2014-05-12 |
2020-04-01 |
Conatus Pharmaceuticals Inc |
Tratamiento con inhibidor de caspasa emricasan de las complicaciones por las enfermedades hepáticas crónicas
|
MA47849A
(fr)
|
2014-05-28 |
2020-01-29 |
Agenus Inc |
Anticorps anti-gitr et leurs procédés d'utilisation
|
WO2015195474A1
(en)
|
2014-06-18 |
2015-12-23 |
Biotheryx, Inc. |
Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating inflammatory, neurodegenerative, or immune-mediated diseases
|
GB201411423D0
(en)
*
|
2014-06-26 |
2014-08-13 |
Ge Healthcare As |
Lipid sterilisation method
|
US9499514B2
(en)
|
2014-07-11 |
2016-11-22 |
Celgene Corporation |
Antiproliferative compounds and methods of use thereof
|
JP6543342B2
(ja)
|
2014-08-14 |
2019-07-10 |
アルハマドシャー,マモウン,エム. |
血清半減期を延長するための、調節可能リンカーを介した薬学的活性剤とトランスサイレチンリガンドのコンジュゲーション
|
CA2960284A1
(en)
|
2014-09-12 |
2016-03-17 |
Tobira Therapeutics, Inc. |
Cenicriviroc combination therapy for the treatment of fibrosis
|
WO2016065264A1
(en)
|
2014-10-24 |
2016-04-28 |
Biogen Ma Inc. |
Diterpenoid derivatives and methods of use thereof
|
US10925579B2
(en)
|
2014-11-05 |
2021-02-23 |
Otsuka Medical Devices Co., Ltd. |
Systems and methods for real-time tracking of a target tissue using imaging before and during therapy delivery
|
US10500227B2
(en)
*
|
2014-12-03 |
2019-12-10 |
University Of Cincinnati |
Bioactive gas-encapsulated echogenic liposomes and methods for treating cardiovascular disease
|
PT3800202T
(pt)
|
2014-12-11 |
2023-01-05 |
Pf Medicament |
Anticorpos anti-c10orf54 e suas utilizações
|
EP3237450B1
(de)
|
2014-12-22 |
2021-03-03 |
The Rockefeller University |
Anti-mertk-antikörper und verwendungen davon
|
TWI703133B
(zh)
|
2014-12-23 |
2020-09-01 |
美商艾克斯基製藥公司 |
3,5-二胺基吡唑激酶抑制劑
|
CA2972423A1
(en)
|
2014-12-31 |
2016-07-07 |
Lantheus Medical Imaging, Inc. |
Lipid-encapsulated gas microsphere compositions and related methods
|
US9676776B2
(en)
|
2015-01-20 |
2017-06-13 |
Xoc Pharmaceuticals, Inc. |
Isoergoline compounds and uses thereof
|
JP6856532B2
(ja)
|
2015-01-20 |
2021-04-07 |
エックスオーシー ファーマシューティカルズ インコーポレイテッドXoc Pharmaceuticals, Inc |
エルゴリン化合物およびその使用
|
CN107428749B
(zh)
|
2015-01-28 |
2020-07-24 |
上海复旦张江生物医药股份有限公司 |
取代的咪唑并[1,2-α]吡啶-2-基胺化合物及其药物组合物和使用方法
|
BR112017015880A2
(pt)
|
2015-03-03 |
2018-07-31 |
Kymab Ltd |
anticorpos, usos e métodos
|
PE20180672A1
(es)
|
2015-05-29 |
2018-04-19 |
Agenus Inc |
Anticuerpos anti-ctla-4 y metodos de uso de los mismos
|
US10656025B2
(en)
|
2015-06-10 |
2020-05-19 |
Ekos Corporation |
Ultrasound catheter
|
CN104984338A
(zh)
*
|
2015-06-23 |
2015-10-21 |
重庆医科大学 |
笑气作为细胞内超声空化效应增强剂的应用
|
MX2017017015A
(es)
|
2015-06-23 |
2018-02-26 |
Neurocrine Biosciences Inc |
Inhibidores de transportador de monoamina vesicular tipo 2 (vmat2) para tratar enfermedades o trastornos neurologicos.
|
WO2017040790A1
(en)
|
2015-09-01 |
2017-03-09 |
Agenus Inc. |
Anti-pd-1 antibodies and methods of use thereof
|
CN115322188A
(zh)
|
2015-10-30 |
2022-11-11 |
纽罗克里生物科学有限公司 |
Valbenazine盐及其多晶形物
|
WO2017079566A1
(en)
|
2015-11-05 |
2017-05-11 |
Conatus Pharmaceuticals, Inc. |
Caspase inhibitors for use in the treatment of liver cancer
|
US10112924B2
(en)
|
2015-12-02 |
2018-10-30 |
Astraea Therapeutics, Inc. |
Piperdinyl nociceptin receptor compounds
|
CN108925135A
(zh)
|
2015-12-23 |
2018-11-30 |
纽罗克里生物科学有限公司 |
制备(S)-(2R,3R,11bR)-3-异丁基-9,10-二甲氧基-2,3,4,6,7,11b-六氢-1H-吡啶并[2,1-a]异喹啉-2-基2-氨基-3-甲基丁酸酯二(4-甲基苯磺酸盐)的合成方法
|
WO2017117478A1
(en)
|
2015-12-31 |
2017-07-06 |
Conatus Pharmaceuticals Inc. |
Methods of using caspase inhibitors in treatment of liver disease
|
WO2017120415A1
(en)
|
2016-01-08 |
2017-07-13 |
Celgene Corporation |
Solid forms of 2-(4-chlorophenyl)-n-((2-2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl) methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and uses
|
ES2957477T3
(es)
|
2016-01-08 |
2024-01-19 |
Celgene Corp |
Compuestos antiproliferativos para usar en el tratamiento de leucemia
|
WO2017151836A1
(en)
|
2016-03-04 |
2017-09-08 |
East Carolina University |
J-series prostaglandin-ethanolamides as novel therapeutics for skin and/or oral disorders
|
US10407437B2
(en)
|
2016-03-08 |
2019-09-10 |
Los Gatos Pharmaceuticals, Inc. |
Camptothecin derivatives and uses thereof
|
WO2017156191A1
(en)
|
2016-03-08 |
2017-09-14 |
Los Gatos Pharmaceuticals, Inc. |
Composite nanoparticles and uses thereof
|
WO2017180589A1
(en)
|
2016-04-11 |
2017-10-19 |
Auspex Pharmaceuticals, Inc. |
Deuterated ketamine derivatives
|
US10047077B2
(en)
|
2016-04-13 |
2018-08-14 |
Skyline Antiinfectives, Inc. |
Deuterated O-sulfated beta-lactam hydroxamic acids and deuterated N-sulfated beta-lactams
|
TWI740937B
(zh)
|
2016-05-04 |
2021-10-01 |
美商藍瑟斯醫學影像公司 |
用於製備超音波顯影劑之裝置及方法
|
EP4190357A1
(de)
|
2016-05-13 |
2023-06-07 |
Institut Pasteur |
Hemmung von beta-2-nikotin-acetylcholinrezeptoren zur behandlung von morbus-alzheimer-pathologie
|
TWI753910B
(zh)
|
2016-05-16 |
2022-02-01 |
美商拜歐斯瑞克斯公司 |
吡啶硫酮、其醫藥組合物及其治療增生性、炎性、神經退化性或免疫介導疾病之治療用途
|
MX2018014387A
(es)
|
2016-05-27 |
2019-03-14 |
Agenus Inc |
Anticuerpos anti proteina inmunoglobulina de linfocitos t y dominio de mucina 3 (tim-3) y métodos para usarlos.
|
US9789210B1
(en)
|
2016-07-06 |
2017-10-17 |
Lantheus Medical Imaging, Inc. |
Methods for making ultrasound contrast agents
|
MA45602A
(fr)
|
2016-07-08 |
2019-05-15 |
Staten Biotechnology B V |
Anticorps anti-apoc3 et leurs méthodes d'utilisation
|
US10919904B2
(en)
|
2016-08-17 |
2021-02-16 |
North Carolina State University |
Northern-southern route to synthesis of bacteriochlorins
|
CN109982687A
(zh)
|
2016-09-19 |
2019-07-05 |
梅制药公司 |
联合疗法
|
AU2017343621B2
(en)
|
2016-10-11 |
2021-12-02 |
Agenus Inc. |
Anti-LAG-3 antibodies and methods of use thereof
|
US11779604B2
(en)
|
2016-11-03 |
2023-10-10 |
Kymab Limited |
Antibodies, combinations comprising antibodies, biomarkers, uses and methods
|
KR102539159B1
(ko)
|
2016-11-07 |
2023-06-02 |
주식회사 뉴라클사이언스 |
서열 유사성을 가진 항-패밀리 19, 멤버 a5 항체 및 그것의 사용 방법
|
WO2018089692A1
(en)
|
2016-11-09 |
2018-05-17 |
Phloronol, Inc. |
Eckol derivatives, methods of synthesis and uses thereof
|
WO2018089427A1
(en)
|
2016-11-09 |
2018-05-17 |
Novomedix, Llc |
Nitrite salts of 1, 1-dimethylbiguanide, pharmaceutical compositions, and methods of use
|
WO2018102252A1
(en)
|
2016-11-30 |
2018-06-07 |
North Carolina State University |
Methods for making bacteriochlorin macrocycles comprising an annulated isocyclic ring and related compounds
|
EP3548007A4
(de)
|
2016-12-01 |
2020-08-12 |
Ignyta, Inc. |
Verfahren zur behandlung von krebs
|
TW202345829A
(zh)
|
2016-12-02 |
2023-12-01 |
美商紐羅克里生物科學有限公司 |
戊苯那嗪(valbenazine)於治療精神分裂症或情感性精神分裂症之用途
|
SI3551660T1
(sl)
|
2016-12-07 |
2024-02-29 |
Agenus Inc. |
Protitelesa proti antictla-4 in načini njihove uporabe
|
EP3551225A1
(de)
|
2016-12-07 |
2019-10-16 |
Agenus Inc. |
Antikörper und verfahren zur verwendung davon
|
MX2019008853A
(es)
|
2017-01-27 |
2019-09-11 |
Neurocrine Biosciences Inc |
Metodos para la administracion de ciertos inhibidores de proteina transportadora transportador de monoamina vesicular-2 (vmat2).
|
BR112019017260A2
(pt)
|
2017-02-17 |
2020-04-14 |
Camris Int Inc |
antiveneno universal
|
NZ755597A
(en)
|
2017-02-17 |
2023-06-30 |
Eidos Therapeutics Inc |
Processes for preparing ag-10, its intermediates, and salts thereof
|
WO2018164996A1
(en)
|
2017-03-06 |
2018-09-13 |
Neurocrine Biosciences, Inc. |
Dosing regimen for valbenazine
|
EP3601351A1
(de)
|
2017-03-27 |
2020-02-05 |
Celgene Corporation |
Verfahren und zusammensetzungen zur reduzierung der immunogenität
|
AU2018253176B2
(en)
|
2017-04-13 |
2023-02-02 |
Agenus Inc. |
Anti-CD137 antibodies and methods of use thereof
|
CA3059133A1
(en)
|
2017-04-21 |
2018-10-25 |
Staten Biotechnology B.V. |
Anti-apoc3 antibodies and methods of use thereof
|
WO2018200605A1
(en)
|
2017-04-26 |
2018-11-01 |
Neurocrine Biosciences, Inc. |
Use of valbenazine for treating levodopa-induced dyskinesia
|
HRP20230941T1
(hr)
|
2017-05-01 |
2023-11-24 |
Agenus Inc. |
Anti-tigit antitijela i postupci njihove primjene
|
JOP20190219A1
(ar)
|
2017-05-09 |
2019-09-22 |
Cardix Therapeutics LLC |
تركيبات صيدلانية وطرق لعلاج أمراض القلب والأوعية الدموية
|
US10085999B1
(en)
|
2017-05-10 |
2018-10-02 |
Arixa Pharmaceuticals, Inc. |
Beta-lactamase inhibitors and uses thereof
|
CA3064274A1
(en)
|
2017-06-01 |
2018-12-06 |
Xoc Pharmaceuticals, Inc. |
Ergoline derivatives for use in medicine
|
WO2019003162A1
(en)
|
2017-06-27 |
2019-01-03 |
Neuracle Science Co., Ltd. |
USE OF ANTIBODIES DIRECTED AGAINST A SIMILARITY FAMILY OF SEQUENCE 19, MEMBER A5, FOR THE TREATMENT OF GLAUCOMA
|
US11155613B2
(en)
|
2017-06-27 |
2021-10-26 |
Neuracle Science Co., Ltd. |
Use of anti-FAM19A5 antibodies for treating fibrosis
|
CN111315774B
(zh)
|
2017-06-27 |
2023-12-22 |
纽洛可科学有限公司 |
抗fam19a5抗体及其用途
|
EP3645040A4
(de)
|
2017-06-27 |
2021-05-05 |
Neuracle Science Co., Ltd |
Verwendung von anti-fam19a5-antikörpern zur krebsbehandlung
|
AU2018324070B2
(en)
|
2017-09-01 |
2023-05-18 |
East Carolina University |
Compounds, compositions, kits, and methods for activating immune cells and/or an immune system response
|
MX2020002841A
(es)
|
2017-09-21 |
2020-07-22 |
Neurocrine Biosciences Inc |
Formulacion de valbenazina de alta dosis y composiciones, metodos y kits relacionados con la misma.
|
US20200230127A1
(en)
|
2017-10-10 |
2020-07-23 |
Neurocrine Biosciences, Inc. |
Methods for the Administration of Certain VMAT2 Inhibitors
|
US10993941B2
(en)
|
2017-10-10 |
2021-05-04 |
Neurocrine Biosciences, Inc. |
Methods for the administration of certain VMAT2 inhibitors
|
JP7039694B2
(ja)
|
2017-10-31 |
2022-03-22 |
スターテン・バイオテクノロジー・ベー・フェー |
抗apoc3抗体およびその使用方法
|
TW201929847A
(zh)
|
2018-01-10 |
2019-08-01 |
美商克拉治療有限責任公司 |
包含二羧酸之醫藥組合物及其治療應用
|
TWI823890B
(zh)
|
2018-01-10 |
2023-12-01 |
美商克拉治療有限責任公司 |
包含苯基磺醯胺之醫藥組合物及其治療應用
|
KR102245539B1
(ko)
*
|
2018-02-12 |
2021-04-29 |
주식회사 지앤피바이오사이언스 |
코어-쉘 구조의 마이크로 입자를 유효성분으로 포함하는 성장인자 유전자 발현 증가용 조성물
|
KR20200135996A
(ko)
|
2018-03-23 |
2020-12-04 |
에이도스 테라퓨틱스, 인코포레이티드 |
Ag10을 사용하여 ttr 아밀로이드증을 치료하는 방법
|
US20210106699A1
(en)
*
|
2018-03-29 |
2021-04-15 |
Case Western Reserve University |
Stabilized nanobubbles and microbubbles for diagnostic and therapeutic application
|
CN112424223A
(zh)
|
2018-04-24 |
2021-02-26 |
纽洛可科学有限公司 |
抗序列相似家族19成员a5的抗体在治疗神经性疼痛中的用途
|
WO2019241555A1
(en)
|
2018-06-14 |
2019-12-19 |
Neurocrine Biosciences, Inc. |
Vmat2 inhibitor compounds, compositions, and methods relating thereto
|
CA3105352A1
(en)
|
2018-06-29 |
2020-01-02 |
Histogen, Inc. |
(s)-3-(2-(4-(benzyl)-3-oxopiperazin-1-yl)acetamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid derivatives and related compounds as caspase inhibitors for treating cardiovascular diseases
|
MA53160A
(fr)
|
2018-07-20 |
2021-05-26 |
Pf Medicament |
Récepteur pour vista
|
CN112867491A
(zh)
|
2018-08-15 |
2021-05-28 |
纽罗克里生物科学有限公司 |
施用某些vmat2抑制剂的方法
|
US11260047B2
(en)
|
2018-08-17 |
2022-03-01 |
Eidos Therapeutics, Inc. |
Formulations of AG10
|
CN112969503A
(zh)
|
2018-10-03 |
2021-06-15 |
斯塔滕生物技术有限公司 |
对人类和食蟹猕猴apoc3具有特异性的抗体和其使用方法
|
AU2019379325A1
(en)
|
2018-11-16 |
2021-06-03 |
Genexine, Inc. |
Method of treating a tumor with a combination of IL-7 protein and an immune checkpoint inhibitor
|
KR20200071198A
(ko)
|
2018-12-10 |
2020-06-19 |
네오이뮨텍, 인코퍼레이티드 |
Nrf2 발현 조절 기반 T 세포 항암면역치료법
|
JP7407461B2
(ja)
|
2018-12-19 |
2024-01-04 |
シャイ・セラピューティクス・エルエルシー |
がん、炎症性疾患、ras病、及び線維性疾患の処置のためのrasスーパーファミリーと相互作用する化合物
|
CN109602450B
(zh)
*
|
2019-01-29 |
2021-04-30 |
北京大学第三医院(北京大学第三临床医学院) |
一种超声腔内探头隔离及导声一体化装置
|
TW202045481A
(zh)
|
2019-02-06 |
2020-12-16 |
美商戴斯阿爾法股份有限公司 |
Il-17a調節物及其用途
|
EP3930847B1
(de)
|
2019-02-26 |
2024-02-14 |
Inspirna, Inc. |
Anti-mertk-antikörper mit hoher affinität und ihre verwendung
|
EP3935042A1
(de)
|
2019-03-07 |
2022-01-12 |
Conatus Pharmaceuticals, Inc. |
Caspase-inhibitoren und verfahren zur verwendung davon
|
CA3138403A1
(en)
|
2019-05-20 |
2020-11-26 |
Christopher J. MACNEVIN |
Narrow emission dyes, compositions comprising same, and methods for making and using same
|
US20220274921A1
(en)
|
2019-07-11 |
2022-09-01 |
Cura Therapeutics, Llc |
Phenyl compounds and pharmaceutical compositions thereof, and their therapeutic applications
|
AU2020311404A1
(en)
|
2019-07-11 |
2022-03-03 |
Cura Therapeutics, Llc |
Sulfone compounds and pharmaceutical compositions thereof, and their therapeutic applications for the treatment of neurodegenerative diseases
|
US10940141B1
(en)
|
2019-08-23 |
2021-03-09 |
Neurocrine Biosciences, Inc. |
Methods for the administration of certain VMAT2 inhibitors
|
CN114585644A
(zh)
|
2019-08-30 |
2022-06-03 |
艾吉纳斯公司 |
抗cd96抗体及其使用方法
|
MX2022003166A
(es)
|
2019-09-16 |
2022-06-29 |
Dice Alpha Inc |
Moduladores de il-17a y usos de los mismos.
|
CN114945409A
(zh)
|
2020-01-13 |
2022-08-26 |
新免疫技术有限公司 |
用il-7蛋白和双特异性抗体的组合治疗肿瘤的方法
|
WO2021151001A1
(en)
|
2020-01-22 |
2021-07-29 |
Outpace Bio, Inc. |
Chimeric polypeptides
|
AU2021217373A1
(en)
|
2020-02-05 |
2022-08-04 |
Neoimmunetech, Inc. |
Method of treating a solid tumor with a combination of an IL-7 protein and CAR-bearing immune cells
|
CA3179635A1
(en)
|
2020-05-29 |
2021-12-02 |
Boulder Bioscience Llc |
Methods for improved endovascular thrombectomy using 3,3'-diindolylmethane
|
EP4168414A1
(de)
|
2020-06-18 |
2023-04-26 |
Shy Therapeutics LLC |
Substituierte thienopyrimidine zur interaktion mit der ras-superfamilie zur behandlung von krebs, entzündlichen erkrankungen, rasopathien und fibrotischen erkrankungen
|
CN111729093B
(zh)
*
|
2020-06-29 |
2022-05-24 |
南京超维景生物科技有限公司 |
一种造影剂成膜剂组合物、造影剂成膜脂液、造影剂及其制备方法
|
CN111617267A
(zh)
*
|
2020-07-07 |
2020-09-04 |
南京大学 |
一种包载全氟化碳的纳米级超声造影剂
|
WO2022061348A1
(en)
|
2020-09-16 |
2022-03-24 |
Biotheryx, Inc. |
Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
|
WO2022087335A1
(en)
|
2020-10-23 |
2022-04-28 |
Biotheryx, Inc. |
Kras protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
|
US20240101629A1
(en)
|
2020-11-02 |
2024-03-28 |
Neoimmunetech, Inc. |
Use of interleukin-7 for the treatment of coronavirus
|
KR20230104175A
(ko)
|
2020-11-05 |
2023-07-07 |
네오이뮨텍, 인코퍼레이티드 |
Il-7 단백질과 뉴클레오타이드 백신의 조합물을 사용한 종양의 치료 방법
|
AU2021402911A1
(en)
|
2020-12-14 |
2023-07-06 |
Biotheryx, Inc. |
Pde4 degraders, pharmaceutical compositions, and therapeutic applications
|
EP4284377A1
(de)
|
2021-01-27 |
2023-12-06 |
Shy Therapeutics LLC |
Verfahren zur behandlung von fibrotischen erkrankungen
|
WO2022165000A1
(en)
|
2021-01-27 |
2022-08-04 |
Shy Therapeutics, Llc |
Methods for the treatment of fibrotic disease
|
CN117642396A
(zh)
|
2021-03-10 |
2024-03-01 |
戴斯分子Sv有限公司 |
αVβ6和αVβ1整联蛋白抑制剂及其用途
|
EP4326721A1
(de)
|
2021-04-22 |
2024-02-28 |
Protego Biopharma, Inc. |
Spirocyclische imidazolidinone und imidazolidindione zur behandlung von leichtkettiger amyloidose
|
EP4347568A1
(de)
|
2021-05-27 |
2024-04-10 |
Protego Biopharma, Inc. |
Heteroaryldiamid-ire1/xbp1s-aktivatoren
|
WO2022251644A1
(en)
|
2021-05-28 |
2022-12-01 |
Lyell Immunopharma, Inc. |
Nr4a3-deficient immune cells and uses thereof
|
KR20240027676A
(ko)
|
2021-06-02 |
2024-03-04 |
라이엘 이뮤노파마, 인크. |
Nr4a3-결핍 면역 세포 및 이의 용도
|
WO2022263357A1
(en)
|
2021-06-14 |
2022-12-22 |
Argenx Iip Bv |
Anti-il-9 antibodies and methods of use thereof
|
WO2022266249A1
(en)
|
2021-06-16 |
2022-12-22 |
Biotheryx, Inc. |
Kras protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
|
WO2022266248A1
(en)
|
2021-06-16 |
2022-12-22 |
Biotheryx, Inc. |
Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
|
WO2023055045A1
(ko)
|
2021-09-29 |
2023-04-06 |
주식회사 엔바이오스 |
코일드 코일 융합 단백질
|
WO2023081923A1
(en)
|
2021-11-08 |
2023-05-11 |
Frequency Therapeutics, Inc. |
Platelet-derived growth factor receptor (pdgfr) alpha inhibitors and uses thereof
|
WO2023130081A1
(en)
|
2021-12-30 |
2023-07-06 |
Neoimmunetech, Inc. |
Method of treating a tumor with a combination of il-7 protein and vegf antagonist
|
WO2023129577A1
(en)
|
2022-01-03 |
2023-07-06 |
Lilac Therapeutics, Inc. |
Cyclic thiol prodrugs
|
US20230348909A1
(en)
|
2022-03-30 |
2023-11-02 |
Biomarin Pharmaceutical Inc. |
Dystrophin exon skipping oligonucleotides
|
GB2619907A
(en)
|
2022-04-01 |
2023-12-27 |
Kanna Health Ltd |
Novel crystalline salt forms of mesembrine
|
WO2023201282A1
(en)
|
2022-04-14 |
2023-10-19 |
Bristol-Myers Squibb Company |
Novel gspt1 compounds and methods of use of the novel compounds
|
US20230416741A1
(en)
|
2022-05-05 |
2023-12-28 |
Biomarin Pharmaceutical Inc. |
Method of treating duchenne muscular dystrophy
|
WO2023220640A1
(en)
|
2022-05-10 |
2023-11-16 |
Biotheryx, Inc. |
Cdk protein degraders, pharmaceutical compositions, and therapeutic applications
|
WO2023225665A1
(en)
|
2022-05-19 |
2023-11-23 |
Lyell Immunopharma, Inc. |
Polynucleotides targeting nr4a3 and uses thereof
|
WO2024054832A1
(en)
|
2022-09-09 |
2024-03-14 |
Innovo Therapeutics, Inc. |
CK1α AND DUAL CK1α / GSPT1 DEGRADING COMPOUNDS
|
WO2024073473A1
(en)
|
2022-09-30 |
2024-04-04 |
Boulder Bioscience Llc |
Compositions comprising 3,3'-diindolylmethane for treating non-hemorrhagic closed head injury
|